full
border
#666666
http://www.lennonsearch.com/wp-content/themes/smartbox-installable/
http://www.lennonsearch.com/
#26ADE4
style3
Over 25 Years Of Expertise
828-403-6096

Archive for October, 2014

31
Oct

In an uncommon move, the FDA has publicly weighed in on an in-development drug, clarifying the status of Sarepta Therapeutics’ closely watched Duchenne muscular dystrophy treatment eteplirsen in light of an earlier setback that tanked the biotech’s shares. …read more Source: FDA pulls back the curtain on Sarepta’s latest DMD delay     

default
Loading posts...
link_magnifier
#5C5C5C
off
fadeInDown
loading
#5C5C5C
off